(Q40569578)

21 September 2017

title

Treatment of occluded central venous catheters with alteplase: results in 1,064 patients (English)

1 reference

21 September 2017

0 references

Charles P Semba

1

1 reference

21 September 2017

Steven R Deitcher

2

1 reference

21 September 2017

Xin Li

3

1 reference

21 September 2017

Laura Resnansky

4

1 reference

21 September 2017

Tri Tu

5

1 reference

21 September 2017

Edward R McCluskey

6

1 reference

21 September 2017

Cardiovascular thrombolytic to Open Occluded Lines Investigators

7

1 reference

21 September 2017

publication date

1 December 2002

1 reference

Journal of Vascular and Interventional Radiology

21 September 2017

published in

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

12

1 reference

21 September 2017

page(s)

1199-1205

1 reference

Recent trends in central venous catheter placement: a comparison of interventional radiology with other specialties.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

Reporting standards for central venous access. Technology Assessment Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961965-4

7 January 2021

10.1016/S1051-0443(07)61965-4

Identifiers

DOI

1 reference

21 September 2017

1 reference